MQS Management’s Quest Diagnostics DGX Stock Holding History

MQS Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,209	Closed	-$557K	–	434
2025 Q4	$557K	Buy	+3,209	New	+$584K	0.33%	91
2024 Q4	–	Sell	-1,332	Closed	-$207K	–	121
2024 Q3	$207K	Buy	+1,332	New	+$199K	0.12%	365
2024 Q1	–	Sell	-3,612	Closed	-$498K	–	510
2023 Q4	$498K	Sell	3,612 -2,535	-41%	-$333K	0.28%	121
2023 Q3	$749K	Buy	+6,147	New	+$819K	0.46%	34

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

MQS Management's DGX Position: Q1 2026 in Review

MQS Management sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 3,209 shares — an estimated $557K sold.

MQS Management first reported a position in DGX in Q3 2023 and held it in 4 quarters. The position peaked at $749K in Q3 2023. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

MQS Management reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
MQS Management sold 3,209 Quest Diagnostics shares in Q1 2026, an estimated $557K.
MQS Management first reported a position in Quest Diagnostics in Q3 2023 and held it in 4 quarters.
MQS Management's Quest Diagnostics position peaked at $749K in Q3 2023.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on MQS Management's 13F filing for Q1 2026, filed 23 Apr 2026.